These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27733953)

  • 1. Predictors of Calf Arterial Compliance in Male Veterans With Psychiatric Diagnoses.
    Koola MM; Sorkin JD; Fargotstein M; Brown WV; Cuthbert B; Hollis J; Raines JK; Duncan EJ
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27733953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced arterial compliance in patients with psychiatric diagnoses.
    Koola MM; Brown WV; Qualls C; Cuthbert B; Hollis JP; Kelly DL; Le NA; Raines J; Duncan EJ
    Schizophr Res; 2012 May; 137(1-3):251-3. PubMed ID: 22377105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index identified as an independent predictor of psychiatric readmission.
    Manu P; Khan S; Radhakrishnan R; Russ MJ; Kane JM; Correll CU
    J Clin Psychiatry; 2014 Jun; 75(6):e573-7. PubMed ID: 25004198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic syndrome and its constituting variables in atypical antipsychotic-treated subjects: comparison with other drug treatments, drug-free psychiatric patients, first-degree relatives and the general population in Venezuela.
    Baptista T; Serrano A; Uzcátegui E; ElFakih Y; Rangel N; Carrizo E; Fernández V; Connell L; de Baptista EA; Quiroz S; Uzcátegui M; Rondón J; Matos Y; Uzcátegui L; Gómez R; Valery L; Novoa-Montero D
    Schizophr Res; 2011 Mar; 126(1-3):93-102. PubMed ID: 21071179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
    Sankaranarayanan J; Puumala SE
    Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smokers exhibit an altered Doppler analog waveform during peripheral arterial examination.
    Terenzi T; Gallagher D; De Meersman R
    J Manipulative Physiol Ther; 1995 May; 18(4):211-8. PubMed ID: 7636410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of arterial compliance in the thigh in predicting exercise capacity in individuals without coronary heart disease.
    Willens HJ; Chirinos JA; Brown WV; Davis WW; Herrington DM; Mosca L; Homma S; Moussa M; Walker G; Raines JK
    Am J Cardiol; 2005 Jul; 96(2):306-10. PubMed ID: 16018862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome: relative risk associated with post-traumatic stress disorder (PTSD) severity and antipsychotic medication use.
    Heppner PS; Lohr JB; Kash TP; Jin H; Wang H; Baker DG
    Psychosomatics; 2012; 53(6):550-8. PubMed ID: 23157993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in body mass index z-scores and weight status in a Dutch pediatric psychiatric population with and without use of second-generation antipsychotics.
    de Hoogd S; Overbeek WA; Heerdink ER; Correll CU; de Graeff ER; Staal WG
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):166-73. PubMed ID: 22506734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of peripheral arterial compliance and standard cardiovascular risk factors.
    Willens HJ; Davis W; Herrington DM; Wade K; Kesler K; Mallon S; Brown WV; Reiber JH; Raines JK
    Vasc Endovascular Surg; 2003; 37(3):197-206. PubMed ID: 12799729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study.
    Meyer JM; Pandina G; Bossie CA; Turkoz I; Greenspan A
    Clin Ther; 2005 Dec; 27(12):1930-41. PubMed ID: 16507379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
    Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
    Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood predictors of antipsychotic use among young people in Finland.
    Gyllenberg D; Sourander A; Helenius H; Sillanmäki L; Huttunen J; Piha J; Kumpulainen K; Tamminen T; Moilanen I; Almqvist F
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):964-71. PubMed ID: 22473622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.
    Gebhardt S; Haberhausen M; Heinzel-Gutenbrunner M; Gebhardt N; Remschmidt H; Krieg JC; Hebebrand J; Theisen FM
    J Psychiatr Res; 2009 Mar; 43(6):620-6. PubMed ID: 19110264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
    Schneiderhan ME; Batscha CL; Rosen C
    Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.